Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB
EB 病毒 LMP1 激活 NF-kB 的遗传和蛋白质组学分析
基本信息
- 批准号:8284169
- 负责人:
- 金额:$ 17.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2015-06-30
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAffectApoptosisAutoimmune ProcessAutoimmunityB-LymphocytesBiochemicalBiochemical GeneticsBiological AssayCancerousCell DeathCell ProliferationCell SurvivalCellsChemicalsClinicalCommunicable DiseasesComplexCytoplasmic TailDeubiquitinating EnzymeDevelopmentDiseaseDrug Delivery SystemsEnzyme InhibitionEnzymesEpithelialEpithelial CellsEpstein-Barr Virus InfectionsEpstein-Barr virus LMP-1 proteinGeneticGenetic TranscriptionGrantGrowthHIVHodgkin DiseaseHost DefenseHumanHuman GenomeHuman Herpesvirus 4HypersensitivityI Kappa B-AlphaImmuneImmunocompromised HostImmunologic ReceptorsImmunologic SurveillanceImmunologyInflammationKnowledgeLigandsLymphomaLymphoproliferative DisordersMAP3K7 geneMAP3K7IP1 geneMalignant NeoplasmsMammalian CellMediatingMembrane ProteinsMitogen-Activated Protein KinasesNF-kappa BNasopharynx CarcinomaNuclearOncogene ProteinsOncogenesOncogenicPathway interactionsPhosphoric Monoester HydrolasesPhosphotransferasesPrecursor B-LymphoblastPreventionProteinsProteomicsRNA InterferenceReporterResearchResearch PersonnelRoleSignal TransductionSiteSmall Interfering RNASystems BiologyTRAF6 geneTherapeuticThroat CancerToxic effectTrainingTransplantationVirus DiseasesWorkbasecareercell growthcell transformationchemotherapydesignfunctional groupgammaherpesvirusgenetic analysisgenome wide association studygenome-wideinhibitor/antagonistinterestloss of functionlymphoblastmicrobialneoplasticnovelpersistent EBV infectionpublic health relevancescaffoldsmall moleculetherapeutic targettraffickingtranscription factortumortumorigenesisubiquitin ligaseubiquitin-specific proteasevirology
项目摘要
DESCRIPTION (provided by applicant): The Epstein Barr Virus (EBV) is an oncogenic gamma-herpesvirus that is associated with Hodgkin disease and anaplasmic nasopharyngeal carcinoma. EBV infection is particularly hazardous with advanced HIV disease or transplant, where EBV-encoded proteins drive aberrant cell growth in the absence of immune surveillance. The principal EBV oncogene, Latent Membrane Protein 1 (LMP1), promotes cell survival and proliferation by mimicking activated immune receptors. Through incompletely defined pathways, LMP1 potently stimulates Nuclear Factor Kappa B (NF-kB), transcription factors that control inflammation, cell survival and growth. EBV- transformed cells rely on constitutive NF-kB activation, and rapidly undergo apoptosis upon NF-kB blockade. Side-effects preclude the clinical use of currently available NF-kB inhibitors, though LMP1-selective drug targets may afford substantially less toxicity. It is therefore important to define how LMP1 activates NF-kB. I have carried out a human genome-wide siRNA screen for cellular modulators of LMP1 canonical NF-kB activation. Hits that either suppress or enhance LMP1 activation of NF-kB have been validated with secondary screens. The screens have implicated numerous proteins in LMP1 function, including novel factors not previously associated with NF-kB. I will carry out hypothesis-based and larger-scale secondary assays to identify critical missing components of LMP1 NF-kB activation in both epithelial cells and B lymphoblasts. I will pursue detailed biochemical analysis of several targets of particular interest, including potentially druggable enzymes and functionally clustered hits. Secondary screens will further stratify hits into functional groups based on whether they affect LMP1 expression, subcellular trafficking, and where they function within the LMP1/NF-kB pathway. Cellular factors uniquely employed by LMP1, but not by immune receptor pathways, may serve as important therapeutic targets for treatment of EBV-driven malignancies. Likewise, these studies may reveal important general mechanisms of NF-kB activation, with implications for allergy, autoimmunity, and host-defense.
PUBLIC HEALTH RELEVANCE: Persistent Epstein Barr virus infection is an important cause of certain lymphoma and throat cancers. This project will better define how EBV subverts cellular machinery to drive cancerous growth of infected cells. Ultimately, it is hoped that knowledge gained from these studies may enable the development of chemotherapies that specifically block EBV function.
描述(由申请人提供):eb病毒(EBV)是一种与霍奇金病和无浆性鼻咽癌相关的致癌γ疱疹病毒。EBV感染在晚期HIV疾病或移植中尤其危险,EBV编码的蛋白质在缺乏免疫监视的情况下驱动异常细胞生长。EBV的主要致癌基因潜伏膜蛋白1 (Latent Membrane Protein 1, LMP1)通过模拟激活的免疫受体来促进细胞存活和增殖。通过不完全确定的途径,LMP1有效刺激核因子κ B (NF-kB),这是控制炎症、细胞存活和生长的转录因子。EBV转化的细胞依赖于组成型NF-kB激活,并在NF-kB阻断后迅速发生凋亡。尽管lmp1选择性药物靶点的毒性可能会大大降低,但目前可用的NF-kB抑制剂的副作用阻碍了其临床应用。因此,确定LMP1如何激活NF-kB是很重要的。我对LMP1典型NF-kB激活的细胞调节剂进行了人类全基因组siRNA筛选。抑制或增强NF-kB的LMP1激活已经通过二次筛选得到验证。筛选涉及LMP1功能中的许多蛋白质,包括以前未与NF-kB相关的新因子。我将进行基于假设和更大规模的二次分析,以确定上皮细胞和B淋巴细胞中LMP1 NF-kB激活的关键缺失成分。我将对几个特别感兴趣的目标进行详细的生化分析,包括潜在的可药物酶和功能聚集点。二级筛选将进一步根据它们是否影响LMP1表达、亚细胞运输以及它们在LMP1/NF-kB通路中的作用,将击中物分层为功能组。LMP1独特利用的细胞因子,而不是免疫受体途径,可能是治疗ebv驱动的恶性肿瘤的重要治疗靶点。同样,这些研究可能揭示NF-kB活化的重要一般机制,对过敏、自身免疫和宿主防御有影响。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Benjamin Elison Gewurz其他文献
Benjamin Elison Gewurz的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Benjamin Elison Gewurz', 18)}}的其他基金
Characterization of Epstein-Barr Virus Subversion of the Host SMC5/6 Restriction Pathway
Epstein-Barr 病毒颠覆宿主 SMC5/6 限制途径的特征
- 批准号:
10679118 - 财政年份:2023
- 资助金额:
$ 17.99万 - 项目类别:
Methionine and PI3K Metabolism Drive CIMP in EBV Epithelial Cancers
蛋氨酸和 PI3K 代谢驱动 EBV 上皮癌中的 CIMP
- 批准号:
10627692 - 财政年份:2023
- 资助金额:
$ 17.99万 - 项目类别:
Regulation of the Epstein-Barr Virus Lytic Switch
Epstein-Barr 病毒裂解开关的调节
- 批准号:
10643950 - 财政年份:2021
- 资助金额:
$ 17.99万 - 项目类别:
Regulation of the Epstein-Barr Virus Lytic Switch
Epstein-Barr 病毒裂解开关的调节
- 批准号:
10317642 - 财政年份:2021
- 资助金额:
$ 17.99万 - 项目类别:
Regulation of the Epstein-Barr Virus Lytic Switch
Epstein-Barr 病毒裂解开关的调节
- 批准号:
10445326 - 财政年份:2021
- 资助金额:
$ 17.99万 - 项目类别:
Epstein-Barr virus LMP1 mediated oncogenicity
EB 病毒 LMP1 介导的致癌性
- 批准号:
10676959 - 财政年份:2019
- 资助金额:
$ 17.99万 - 项目类别:
Epstein-Barr virus LMP1 mediated oncogenicity
EB 病毒 LMP1 介导的致癌性
- 批准号:
10020965 - 财政年份:2019
- 资助金额:
$ 17.99万 - 项目类别:
Metabolic Network Remodeling in Epstein-Barr Virus Lymphomagenesis
EB 病毒淋巴瘤发生中的代谢网络重塑
- 批准号:
9899193 - 财政年份:2018
- 资助金额:
$ 17.99万 - 项目类别:
Metabolic Network Remodeling in Epstein-Barr Virus Lymphomagenesis
EB 病毒淋巴瘤发生中的代谢网络重塑
- 批准号:
10353408 - 财政年份:2018
- 资助金额:
$ 17.99万 - 项目类别:
Genetic and Proteomic Analysis of Epstein-Barr Virus LMP1 Activation of NF-kB
EB 病毒 LMP1 激活 NF-kB 的遗传和蛋白质组学分析
- 批准号:
8068346 - 财政年份:2010
- 资助金额:
$ 17.99万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 17.99万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 17.99万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 17.99万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 17.99万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 17.99万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 17.99万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 17.99万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 17.99万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 17.99万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 17.99万 - 项目类别:
Studentship